Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Factor D: Can blocking immune system pathway stop COVID-19?

COVID UPDATE: Decrease in daily active cases in India

Science and technology help in simplifying tumour testing

Factor D: Can blocking immune system pathway stop COVID-19?
  • BiotechToday
  • World

Factor D: Can blocking immune system pathway stop COVID-19?

bioxone October 13, 2020October 13, 2020

Husna, Amity University Kolkata

As the world is waiting anxiously for a powerful and effective vaccine against covid-19, researchers are also trying to identify how coronavirus attacks the body to stop its devastating impact. One such possible way has been discovered in a recent study by researchers of John Hopkins University. This can be done by blocking a particular protein which enables the virus to turn the immune system against healthy cells of our body.

The protein is known as Factor D which on inhibition will also reduce the deadly inflammatory responses that numerous patients get on being infected. The SARS-CoV-2 virus attaches to a healthy targeted cell of the body to cause infection using the spike proteins present on its surface. The spikes do this by seizing heparan sulphate which is a complex sugar molecule found on cell-surface of lungs, blood vessels and smooth muscles as a result of which Factor H is prevented from using sugar molecule to bind with cells. Factor H regulates the chemical signals that trigger inflammation thus preventing the immune system from harming healthy cells. Without this protection, the lungs, heart, kidneys and other organs will be destroyed by the defence mechanism of our body. The SARS-CoV-2 virus activates a cascading series of biological reactions known as an alternative pathway of complement (APC) when it ties with heparan sulphate which results in inflammation and cell destruction if misread by the immune system.

 So, the research team used normal human blood serum and three sub-units of  SARS-CoV-2 spike protein to find exactly how the virus activates APC, hijacks the immune system and destroys normal cells. They discovered that S1 and S2 sub-units bind virus to heparan sulphate leading to activation of APC cascade and blockage of  Factor H due to which Factor H confers a misdirected immune response. Further, they found that upon blocking another complement protein Factor D, which works immediately upstream within the pathway from Factor H, they were able to stop the destructive chain of events triggered by SARS-CoV-2.

Also read: CAN PHYSICAL EXERCISES IMPROVE HEALTH OF BREAST CANCER SURVIVORS?

Source: https://health.economictimes.indiatimes.com/amp/news/industry/blocking-immune-system-pathway-may-stop-covid-19-johns-hopkins-study/78596131

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged (APC) Alternative pathway of complement cascade series CORONAVIRUS COVID-19 Factor D Factor H heparin sulphate human blood serum immune system inflammation SARS-CoV-2 spike protein VACCINE

3 thoughts on “Factor D: Can blocking immune system pathway stop COVID-19?”

  1. Diwita Roy says:
    October 13, 2020 at 4:41 pm

    Good content 👍👍

    Reply
    1. Husna says:
      October 13, 2020 at 4:42 pm

      Thank you❤️

      Reply
  2. Farah Noor says:
    October 16, 2020 at 9:19 pm

    The description is so clear & precise. MashaAllah. Thankyou Husna! We all are desperately waiting & praying for an effective vaccine to be produced.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Science and technology help in simplifying tumour testing

bioxone October 14, 2020

Camelia Bhattacharyya, Amity University Kolkata We live in a world that needs more fast methods to be used from day-to-day problems to higher or complicated forms of problems; the healthcare system is not excluded from these. Patients are needing immediate treatment after quick testing which mostly depends on the equipment and the techniques used. This […]

Tumour

Related Post

  • BiotechToday
  • World

One-pot Visual RT PCR as a diagnostic test for SARS-CoV-2

bioxone October 29, 2020October 28, 2020

Sumedha Guha, Techno India University The outbreak of the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) towards the latter part of 2019 had brought mankind to a screeching halt for some time. The global pandemic that followed in its wake is something that every nation of the world is still grappling hard to recover from. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

SARS-CoV-2: CAN INCORPORATE THEIR GENOME IN THE HOST CELL

bioxone February 25, 2021February 25, 2021

PRAGYA SANTRA, AMITY UNIVERSITY COVID-19 drastically hit 2020, an eye-witnessed pandemic for us all. Analysis from many patients suffering from COVID-19 the second time suggests that the immune system failed to ward off the second thrash of the virus. A recent study now puts light on the fact. Reports highlight that the coronavirus mutates itself […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Neutrophil-derived Nanovesicles: A Novel Drug Delivery System

bioxone December 13, 2020December 12, 2020

Sayak Banerjee. Amity University Kolkata Scientists at Washington State University (WSU) discovered that other than immune cells, neutrophils also might play a major role in defense against infection, through a new drug delivery technology. Neutrophils are the most common type of white blood cells (WBCs) that lead the body’s immune system response. They established a […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy